Opinion | Published:

Long-term effects of adolescent obesity: time to act

Nature Reviews Endocrinology volume 14, pages 183188 (2018) | Download Citation

Abstract

Obesity in adolescence will probably have major implications not only for the affected adolescents but also for society. Those who have obesity during adolescence usually have obesity into adulthood, which causes many medical and psychological issues that can result in premature death. Furthermore, obesity in adolescents is associated with a range of social problems, including difficulties securing an apprenticeship or a job or finding a partner. Adolescents with obesity are also at increased risk of having children with obesity later in life. All these consequences lead to high costs for the health-care system. Although efficient treatment options are available that have been proven in randomized controlled trials, such as lifestyle interventions for adolescents with obesity and bariatric surgery for adolescents with severe obesity, these interventions frequently fail in clinical practice as treatment adherence is low in adolescents and most adolescents with obesity do not seek medical care. Therefore, improving treatment adherence and identifying treatment barriers are necessary.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Prevalence of severe childhood obesity in England: 2006–2013. Arch. Dis. Child 100, 631–636 (2015).

  2. 2.

    & Childhood obesity trends from primary care electronic health records in England between 1994 and 2013: population-based cohort study. Arch. Dis. Child 100, 214–219 (2015).

  3. 3.

    GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N. Engl. J. Med. 377, 13–27 (2017).

  4. 4.

    et al. Cardiovascular risk in 26,008 European overweight children as established by a multicenter database. Obesity 16, 1672–1679 (2008).

  5. 5.

    et al. Psychological consequences of childhood obesity: psychiatric comorbidity and prevention. Adolesc. Health Med. Ther. 7, 125–146 (2016).

  6. 6.

    , , , & Predicting obesity in young adulthood from childhood and parental obesity. N. Engl. J. Med. 337, 869–873 (1997).

  7. 7.

    et al. Body-mass index in 2.3 million adolescents and cardiovascular death in adulthood. N. Engl. J. Med. 374, 2430–2440 (2016).

  8. 8.

    , & Childhood body-mass index and the risk of coronary heart disease in adulthood. N. Engl. J. Med. 357, 2329–2337 (2007).

  9. 9.

    & Childhood obesity and adult morbidities. Am. J. Clin. Nutr. 91, 1499S–1505S (2010).

  10. 10.

    , & A critical review: early life nutrition and prenatal programming for adult disease. J. Clin. Nurs. 24, 3716–3729 (2015).

  11. 11.

    & Early factors leading to later obesity: interactions of the microbiome, epigenome, and nutrition. Curr. Probl. Pediatr. Adolesc. Health Care 45, 134–142 (2015).

  12. 12.

    et al. An evolving scientific basis for the prevention and treatment of pediatric obesity. Int. J. Obes. 38, 887–905 (2014).

  13. 13.

    & Mechanisms affecting neuroendocrine and epigenetic regulation of body weight and onset of puberty: potential implications in the child born small for gestational age (SGA). Rev. Endocr. Metab. Disord. 13, 129–140 (2012).

  14. 14.

    , , & Weight loss in children and adolescents. Dtsch. Arztebl Int. 111, 818–824 (2014).

  15. 15.

    et al. Two-year follow-up in 21,784 overweight children and adolescents with lifestyle intervention. Obesity 17, 1196–1199 (2009).

  16. 16.

    et al. Perioperative outcomes of adolescents undergoing bariatric surgery: the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study. JAMA Pediatr. 168, 47–53 (2014).

  17. 17.

    & Should bariatric surgery be performed in adolescents? Eur. J. Endocrinol. 176, D1–D15 (2017).

  18. 18.

    et al. Trends in obesity prevalence among children and adolescents in the United States, 1988–1994 through 2013–2014. JAMA 315, 2292–2299 (2016).

  19. 19.

    World Health Organisation. Obesity and overweight factsheet no 311. WHO (2017).

  20. 20.

    & Prevalence of overweight among children in Europe. Obes. Rev. 4, 195–200 (2003).

  21. 21.

    & Prevalence and trends in obesity and severe obesity among children in the United States, 1999–2012. JAMA Pediatr. 168, 561–566 (2014).

  22. 22.

    Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease. Am. Heart J. 121, 1283–1288 (1991).

  23. 23.

    et al. The metabolic syndrome in children and adolescents — an IDF consensus report. Pediatr. Diabetes 8, 299–306 (2007).

  24. 24.

    , & Metabolic syndrome — a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet. Med. 23, 469–480 (2006).

  25. 25.

    , , & Relationship between carotid intima-media thickness and metabolic syndrome in adolescents. J. Pediatr. 163, 327–332 (2013).

  26. 26.

    , , & Arterial stiffening, insulin resistance and acanthosis nigricans in a community sample of adolescents with obesity. Int. J. Obes. 41, 1454–1456 (2017).

  27. 27.

    & The intima media thickness and coronary risk factors. Int. Angiol. 20, 118–125 (2001).

  28. 28.

    et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. N. Engl. J. Med. 376, 1419–1429 (2017).

  29. 29.

    et al. Diabetes mellitus type 2 in childhood and adolescence in Germany and parts of Austria. Eur. J. Pediatr. 164, 705–707 (2005).

  30. 30.

    , , , & Type 2 diabetes in children in the Netherlands: the need for diagnostic protocols. Eur. J. Endocrinol. 157, 175–180 (2007).

  31. 31.

    , , & Cardiometabolic risks and severity of obesity in children and young adults. N. Engl. J. Med. 373, 1307–1317 (2015).

  32. 32.

    , & Health-related quality of life of severely obese children and adolescents. JAMA 289, 1813–1819 (2003).

  33. 33.

    & Stigmatization of overweight and obese peers among children. Front. Psychol. 8, 524 (2017).

  34. 34.

    , & Childhood obesity. Lancet 375, 1737–1748 (2010).

  35. 35.

    et al. Body mass index as a predictor of healthy and disease-free life expectancy between ages 50 and 75: a multicohort study. Int. J. Obes. 41, 769–775 (2017).

  36. 36.

    , , , & Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N. Engl. J. Med. 327, 1350–1355 (1992).

  37. 37.

    et al. Maternal obesity: lifelong metabolic outcomes for offspring from poor developmental trajectories during the perinatal period. Arch. Med. Res. 47, 1–12 (2016).

  38. 38.

    & Genomic imprinting: parental influence on the genome. Nat. Rev. Genet. 2, 21–32 (2001).

  39. 39.

    & Epigenetics and obesity: the devil is in the details. BMC Med. 8, 88 (2010).

  40. 40.

    et al. PGC1α promoter methylation in blood at 5–7 years predicts adiposity from 9 to 14 years (EarlyBird 50). Diabetes 63, 2528–2537 (2014).

  41. 41.

    et al. Association between maternal body mass index in early pregnancy and incidence of cerebral palsy. JAMA 317, 925–936 (2017).

  42. 42.

    & Pregnancy: an underutilized window of opportunity to improve long-term maternal and infant health — an appeal for continuous family care and interdisciplinary communication. Front. Pediatr. 5, 69 (2017).

  43. 43.

    , , & Economic evaluation of obesity prevention in early childhood: methods, limitations and recommendations. Int. J. Environ. Res. Public Health 13, 911 (2016).

  44. 44.

    & The impact of childhood obesity on health and health service use. Health Serv. Res. (2017).

  45. 45.

    et al. Cost effectiveness of a multi-component school-based physical activity intervention targeting adolescents: the 'Physical Activity 4 Everyone' cluster randomized trial. Int. J. Behav. Nutr. Phys. Act. 13, 94 (2016).

  46. 46.

    , & Lifetime indirect cost of childhood overweight and obesity: a decision analytic model. Obesity 24, 200–206 (2016).

  47. 47.

    et al. Patterns of health risk behaviors among job-seekers: a latent class analysis. Int. J. Public Health 60, 111–119 (2015).

  48. 48.

    et al. The economic burden of obesity in germany: results from the population-based KORA studies. Obes. Facts 9, 397–409 (2016).

  49. 49.

    & Estimating the medical care costs of obesity in the United States: systematic review, meta-analysis, and empirical analysis. Value Health 19, 602–613 (2016).

  50. 50.

    , , , & Children with diabetes mellitus type 2 in Europe: an underserved population. Arch. Dis. Child 95, 954 (2010).

  51. 51.

    & Diabetes may be undetected in many children in the UK. BMJ 328, 1261–1262 (2004).

  52. 52.

    Lifestyle intervention in childhood obesity: changes and challenges. Nat. Rev. Endocrinol. 9, 607–614 (2013).

  53. 53.

    et al. Screening for obesity and intervention for weight management in children and adolescents: evidence report and systematic review for the US Preventive Services Task Force. JAMA 317, 2427–2444 (2017).

  54. 54.

    et al. Long-term results of an obesity program in an ethnically diverse pediatric population. Pediatrics 127, 402–410 (2011).

  55. 55.

    , , , & Overweight children and adolescents — is there a subjective need for treatment? Int. J. Public Health 54, 112–116 (2009).

  56. 56.

    et al. Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 102, 709–757 (2017).

  57. 57.

    et al. Inter-disciplinary European guidelines on surgery of severe obesity. Int. J. Obes. 31, 569–577 (2007).

  58. 58.

    Intensive therapies for pediatric obesity. Pediatr. Clin. North Am. 48, 1041–1053 (2001).

  59. 59.

    & Long-term drug treatment for obesity: a systematic and clinical review. JAMA 311, 74–86 (2014).

  60. 60.

    , & Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles. Diabetes Obes. Metab. 18, 558–570 (2016).

  61. 61.

    & Roles of gastrointestinal and adipose tissue peptides in childhood obesity and changes after weight loss due to lifestyle intervention. Arch. Pediatr. Adolesc. Med. 164, 131–138 (2010).

  62. 62.

    et al. Long-term persistence of hormonal adaptations to weight loss. N. Engl. J. Med. 365, 1597–1604 (2011).

  63. 63.

    , & Adipocytokines: leptin — the classical, resistin — the controversical, adiponectin — the promising, and more to come. Best Pract. Res. Clin. Endocrinol. Metab. 19, 525–546 (2005).

  64. 64.

    , , & Efficacy and safety of anti-obesity drugs in children and adolescents: systematic review and meta-analysis. Obes. Rev. 11, 593–602 (2010).

  65. 65.

    , , & Biological roles of microRNAs in the control of insulin secretion and action. Physiol. Genom. 49, 1–10 (2017).

  66. 66.

    & Epigenetic epidemiology of the developmental origins hypothesis. Annu. Rev. Nutr. 27, 363–388 (2007).

  67. 67.

    et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42, 937–948 (2010).

  68. 68.

    , , , & Perspectives: molecular genetic research in human obesity. Obes. Rev. 4, 139–146 (2003).

  69. 69.

    et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197–206 (2015).

  70. 70.

    et al. Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits. Nat. Commun. 8, 14977 (2017).

  71. 71.

    et al. Genome-wide physical activity interactions in adiposity — a meta-analysis of 200,452 adults. PLoS Genet. 13, e1006528 (2017).

  72. 72.

    & Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 8, 253–262 (2007).

  73. 73.

    & Epigenetics and environmental chemicals. Curr. Opin. Pediatr. 21, 243–251 (2009).

  74. 74.

    & Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res. C Embryo Today 93, 34–50 (2011).

  75. 75.

    & Adherence to medication. N. Engl. J. Med. 353, 487–497 (2005).

  76. 76.

    et al. Adherence to a lifestyle program for youth with type 2 diabetes and its association with treatment outcome in the TODAY clinical trial. Pediatr. Diabetes (2017).

  77. 77.

    et al. Compliance of pediatric and adolescent cancer patients. Cancer 58, 1179–1184 (1986).

  78. 78.

    & Adolescents' compliance with therapeutic regimens. Psychological and social aspects and intervention. J. Adolesc. Health Care 8, 52–67 (1987).

  79. 79.

    , , , & Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health 6, 566–573 (2003).

  80. 80.

    , & Helping patients follow prescribed treatment: clinical applications. JAMA 288, 2880–2883 (2002).

  81. 81.

    & Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain. Obes. Rev. 6, 67–85 (2005).

  82. 82.

    , & Brief interventions and motivational interviewing with children, adolescents, and their parents in pediatric health care settings: a review. Arch. Pediatr. Adolesc. Med. 159, 1173–1180 (2005).

  83. 83.

    & Treatment programs in overweight and obese children: How to achieve lifestyle changes? Obes. Med. 3, 10–16 (2016).

  84. 84.

    , , , & How can peer group influence the behavior of adolescents: explanatory model. Glob. J. Health Sci. 4, 26–35 (2012).

  85. 85.

    , & Parent-focused childhood and adolescent overweight and obesity ehealth interventions: a systematic review and meta-analysis. J. Med. Internet Res. 18, e203 (2016).

  86. 86.

    et al. Sociocultural influence on obesity and lifestyle in children: a study of daily activities, leisure time behavior, motor skills, and weight status. Obes. Facts 10, 168–178 (2017).

  87. 87.

    et al. Psychosocial predictors and moderators of weight management programme outcomes in ethnically diverse obese youth. Pediatr. Obes. (2016).

  88. 88.

    & Out of sight, out of mind — behavioral and developmental care for rural children. N. Engl. J. Med. 376, 1301–1303 (2017).

  89. 89.

    , , , & Internet-assisted delivery of cognitive behavioural therapy (CBT) for childhood anxiety: systematic review and meta-analysis. J. Anxiety Disord. 29, 83–92 (2015).

  90. 90.

    , , & Interventions for preventing obesity in childhood. A systematic review. Obes. Rev. 2, 149–157 (2001).

  91. 91.

    et al. Differential outcome of the IDEFICS intervention in overweight versus non-overweight children: did we achieve 'primary' or 'secondary' prevention? Obes. Rev. 16 (Suppl. 2), 119–126 (2015).

  92. 92.

    , , & First lessons from the Kiel Obesity Prevention Study (KOPS). Int. J. Obes. 29 (Suppl. 2), S78–S83 (2005).

  93. 93.

    , & School-based interventions to prevent overweight and obesity in prepubertal children: process and 4-years outcome evaluation of the Kiel Obesity Prevention Study (KOPS). Acta Paediatr. 96, 19–25 (2007).

  94. 94.

    , , & Internet use patterns and Internet addiction in children and adolescents with obesity. Pediatr. Obes. (2017).

  95. 95.

    et al. Longitudinal changes in body mass index of children affected by the Great East Japan Earthquake. Int. J. Obes. 41, 606–612 (2017).

  96. 96.

    , , , & Person-centred care in interventions to limit weight gain in pregnant women with obesity — a systematic review. BMC Pregnancy Childbirth 15, 50 (2015).

  97. 97.

    et al. Effectiveness and cost-effectiveness of a cluster-randomized prenatal lifestyle counseling trial: a seven-year follow-up. PLoS ONE 11, e0167759 (2016).

  98. 98.

    et al. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial. Reprod. Health 14, 34 (2017).

  99. 99.

    et al. Effect of an obesity prevention program focused on motivating environments in childhood: a school-based prospective study. Int. J. Obes. 41, 1027–1034 (2017).

  100. 100.

    et al. Promotion and provision of drinking water in schools for overweight prevention: randomized, controlled cluster trial. Pediatrics 123, e661–e667 (2009).

  101. 101.

    & Prevention of childhood obesity by reducing soft drinks. Int. J. Obes. 29 (Suppl. 2), S54–S57 (2005).

  102. 102.

    Sugars and health: a review of current evidence and future policy. Proc. Nutr. Soc. 76, 400–407 (2017).

  103. 103.

    et al. Neighbourhoods for Active Kids: study protocol for a cross-sectional examination of neighbourhood features and children's physical activity, active travel, independent mobility and body size. BMJ Open 6, e013377 (2016).

Download references

Author information

Affiliations

  1. Department of Pediatric Endocrinology, Diabetes, and Nutrition Medicine, Vestische Hospital for Children and Adolescents, University of Witten/Herdecke, Dr. Friedrich Steiner Street 5, Datteln 45711, Germany.

    • Thomas Reinehr

Authors

  1. Search for Thomas Reinehr in:

Competing interests

The author declares no competing financial interests.

Corresponding author

Correspondence to Thomas Reinehr.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrendo.2017.147

Further reading